InvestorsHub Logo
Followers 972
Posts 383062
Boards Moderated 5
Alias Born 06/24/2011

Re: None

Wednesday, 02/23/2022 9:58:30 AM

Wednesday, February 23, 2022 9:58:30 AM

Post# of 177
Flora Pharma is launching a study on the use of cann-a-binoids in patients suffering from Fibromyalgia or chronic pain, with the primary research sites located in the United States and the United Kingdom.

This game-changing research is headed by Flora’s Dr. Annabelle Morgan-Manalo.?

Dr. Annabelle, as she is known, is a cell and developmental biologist from Vanderbilt University, with a background in neuroscience from Georgetown University. She earned her PhD in Cell and Developmental Biology with a focus in Cardio-Oncology and has since become a philanthropist and entrepreneur focused on pharmaceutical innovation and clinical trial research in medical cann-a-bis.?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FLGC News